A prospective study of 42,847 middle-aged and older U.S. men participating in the Health Professionals Follow-up Study has found that a healthy lifestyle is associated with a lower risk of coronary heart disease (CHD), even among men taking antihypertensive or lipid-lowering medications. The research, which is the first to look at the role of a healthy lifestyle and CHD in men in this age group, is published in the July 3, 2006 online edition of Circulation.
The research team, led by Eric Rimm, associate professor of epidemiology and nutrition at Harvard School of Public Health (HSPH) and Stephanie Chiuve, research fellow in nutrition at HSPH, did a 16-year follow-up of men aged 40-75 in the Health Professionals Follow-up Study, a men's health study that began in 1986. The researchers defined healthy lifestyle factors as not smoking, daily exercise, moderate alcohol consumption, a healthy body weight and a healthy diet (based upon the Alternate Healthy Eating Index developed by HSPH, which targets food and nutrients associated with lower risk of chronic disease). The study, which documented 2,183 coronary events, found that men with all five healthy lifestyle factors had a lower risk of CHD compared to men with none of those factors. It also found that 62 percent of coronary events may have been prevented if all men in the study population adhered to all 5 healthy lifestyle factors; for those men taking medications, 57 percent could have been prevented. Men who adopted two or more low-risk factors during the study period (1986-2002) had a 27 percent lower risk of CHD. Overall, for each healthy lifestyle factor, the authors found an inverse association with CHD risk.
Chiuve says the study shows that middle-aged and older men who adopt a healthy lifestyle, including men taking antihypertensive or lipid-lowering medications, have a lower risk of CHD. "It's never too late to make changes to become healthier," she said.
Todd Datz | EurekAlert!
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
19.11.2018 | Event News
09.11.2018 | Event News
06.11.2018 | Event News
19.11.2018 | Materials Sciences
19.11.2018 | Information Technology
19.11.2018 | Life Sciences